Business Context and Reporting Period
This Form 8-K Current Report is filed by Viewbix Inc. (not Quantum X Labs Inc.) for the reporting period of July 31, 2024. The registrant is incorporated in Delaware and maintains its principal office in Tel Aviv, Israel. The filing primarily addresses the entry into a material definitive agreement regarding a securities exchange.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on a corporate transaction rather than periodic financial performance.
Material Changes and Agreements
- Securities Exchange Agreement: On July 31, 2024, Viewbix Inc. entered into an amended and restated securities exchange agreement with Metagramm Software Ltd.
- Transaction Structure: Viewbix agreed to issue 9.99% of its issued and outstanding capital stock (on a post-closing basis) in exchange for 19.99% of Metagramm's issued and outstanding share capital (on a post-closing basis).
- Strategic Rationale: The transaction is driven by anticipated synergies in R&D and sales and marketing.
- Closing Conditions: The parties anticipate closing the agreement following the effectiveness of an uplisting of Viewbix's shares to a national securities exchange.
- Regulatory Status: The shares are being issued in reliance on the exemption from registration requirements under Regulation S.
Guidance, Outlook, and Risks
Outlook: Management expects the transaction to close contingent upon the successful uplisting of the Company's shares to a national securities exchange. The agreement includes customary representations, warranties, and covenants.
Risks and Contingencies: The primary contingency is the regulatory approval and effectiveness of the share uplisting. The filing notes that the representations and warranties are subject to limitations agreed upon by the contracting parties.
Investor Verification Checklist
- Verify the current status of Viewbix Inc.'s application for uplisting to a national securities exchange.
- Confirm the exact post-closing ownership percentages for both Viewbix and Metagramm Software Ltd.
- Review the full text of the Amended and Restated Securities Exchange Agreement (Exhibit 10.1) for specific covenants and termination rights.
- Assess the financial health and operational status of Metagramm Software Ltd. as a counterparty.
- Clarify the discrepancy between the requested company name (Quantum X Labs Inc.) and the actual registrant (Viewbix Inc.).